|
COPYRIGHT 2003 International Medical News Group
SAN FRANCISCO -- No neutralizing antibodies developed in patients receiving repeated injections of botulinum toxin type A in a 16-month, multicenter European trial, it was announced at the annual meeting of the American Academy of Dermatology.
"A robust effect was maintained after repeated treatment cycles," Dr. Markus K. Naumann of the University of Wurzburg (Germany) reported in a poster presented at the meeting.
A total of 307 patients initially enrolled in a 16-week, randomized, double-blind study comparing botulinum...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
